Dr. Wang has 25+ years of research experience and has in-depth knowledge of biopharmaceutical research and the IND and NDA processes. Prior to joining the Group, Dr. Wang served as the deputy general manager at Shanghai Furen Medicine R&D Co., Ltd. from October 2016 to June 2018 and the director of vaccine production in Newlink Genetics Inc., for a special project to fight the Ebola Epidemic from August 2014 to June 2016. In our Group, Dr. Wang leads the teams focused on manufacturing and regulatory compliance.
This person is not in any offices
Sirnaomics
1 followers
Sirnaomics is a clinical stage biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.